In-depth Clinical Oncology Next-Generation Sequencing Market Study:
The study focuses on important participants in the Clinical Oncology Next-Generation Sequencing sector, outlining their strategic goals and growth plans. The study examines a variety of industry tactics, such as mergers and acquisitions, government and business transactions, partnerships and collaborations, joint ventures, brand promotions, and product launches. The most recent Market Research Report provides a complete review of the market, including accurate definitions, classifications, applications, and the industrial chain structure. With independent and expert comments, this study provides useful insights into the current market situation. It focuses on critical areas such market performance, production and consumption rates, demand and supply dynamics, and expected revenue generation over the projection term.
Click the below link for more details: https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Development and Estimation:
The Clinical Oncology Next-Generation Sequencing market size was valued at US $ 7.86 Bn.in 2022 and the total revenue is expected to grow at 20.7% through 2022 to 2029, reaching nearly US$ 2.93 Bn.
Clinical Oncology Next-Generation Sequencing Market Dynamics:
The clinical oncology next-generation sequencing market is likely to lead in the next years, owing to increased cancer prevalence and technological breakthroughs in the field of next-generation sequencing. Furthermore, throughout the projected period, an increase in the preference for NGS over single-gene research is expected to generate significant market potential prospects.
According to the American Cancer Society, 1.7 million new cancer diagnoses and 0.6 million deaths occurred in the United States in 2019. Lung, prostate, bladder, and female breast cancer are the four most common types of cancer worldwide, accounting for 43% of all new cases. As a result, the global growth in cancer incidence rates is predicted to drive up demand for clinical oncology next-generation sequencing.
Clinical Oncology Next-Generation Sequencing Market Scope and Methodology:
The report provides a complete overview of the Clinical Oncology Next-Generation Sequencing market. The study includes a detailed analysis of market trends and highlights to help businesses find opportunities and develop effective market strategies. Primary and secondary data sources were used, allowing for a comprehensive collection of qualitative and quantitative information.The study focuses on the drivers, challenges, main restraints, and opportunities that affect the Clinical Oncology Next-Generation Sequencing market. The market size was determined using a bottom-up technique and segmentation. This segmentation enables the investigation of many factors that influence market growth, either favourably or adversely. The research outlines growing regions that are likely to grow into substantial markets for Clinical Oncology Next-Generation Sequencing. Furthermore, a PESTLE analysis was used to understand the potential impact.
Clinical Oncology Next-Generation Sequencing Market Dividing:
by Technology
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing Centrifuges
Based on technology, the targeted sequencing and resequencing segment grew significantly, accounting for more than 72% of total revenues in 2020. Targeted cancer sequencing panels tend to reduce the cost, time, and volume of data analysed during tumour sample sequencing. Furthermore, tailored panels’ capacity to detect malignant tumours enhances their therapeutic efficacy. NGS panels are clinically effective in 64% of cancer cases, according to a 2020 JCO Precision Oncology analysis.
by Workflow
• Pre Sequencing
• Sequencing
• Data Analysis
According to Workflow, sequencing was the most profitable workflow category, accounting for more than 54% of overall revenue. Sequencing is a critical step in the workflow that necessitates the usage of specialised platforms. The segment’s growth is boosted by an increase in the number of cancer sequencing programmes. The pre-sequencing portion is motivated by major participants’ desire to lower the cost of NGS library planning. The usage of NGS data analysis is projected to increase. The segment’s growth is supported by leading industry players’ attempts to build powerful analytical tools. The Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium sequenced more than 2,600 tumour samples from 38 distinct cancer types.
by Application
• Screening
• Companion Diagnostics
• Other Diagnostics
According to Application, screening contributed for the biggest revenue share of more than 79%. NGS-based research is now regarded to be the most effective method for discovering genetic variations that can be exploited for therapeutic benefit in cancer patients. This method allows physicians to evaluate many gene variants at the same time. The usage of NGS for companion diagnostics is projected to increase as a result of ongoing product development, collaborations, and partnerships between major actors.
by End-User
• Hospitals
• Clinics
• Laboratories
According to End User, the laboratories segment led the market over the projection period, accounting for more than 65 percent of total sales. Setting up dynamic workflows in laboratories is time-consuming. As a result, the bulk of specialised laboratories have established pre-existing workflows based on standard protocols. Furthermore, as NGS assays are rapidly produced and released for clinical usage, thorough protocols for NGS testing methods have been developed. As a result, the majority of FDA-approved assessments rely on established controls, criteria, and performance characteristics to demonstrate the findings’ validity.
For instant access, download your exclusive sample copy of the report right now!
Clinical Oncology Next-Generation Sequencing Market Key Players:
• Illumina, Inc.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• F. Hoffman-La Roche Technologies
• Agilent Technologies
• Myriad Genetics
• Foundation Medicine
• Pacific Bioscience
• Oxford Nanopore Technologies Ltd.
• Beijing Genomics Institute (BGI)
• Perkin Elmer, Inc.
• Paradigm Diagnostics
• Caris Life Sciences
• Partek, Inc.
• Eurofins Scientific S.E.
• Bio Rad Laboratories, Inc.
• Other Key Players
Clinical Oncology Next-Generation Sequencing Market Regional Insights
The Clinical Oncology Next-Generation Sequencing market is broadly segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The report includes a thorough analysis of all the factors, market size, growth rate, and import and export in regions. The Regional Analysis provides the Clinical Oncology Next-Generation Sequencing market status of various countries included in the report.
Key questions answered in the Clinical Oncology Next-Generation Sequencing Market are:
- What is Clinical Oncology Next-Generation Sequencing?
- What was the Clinical Oncology Next-Generation Sequencing market size in 2024?
- What is the growth rate of the Clinical Oncology Next-Generation Sequencing Market?
- Which are the factors expected to drive the Clinical Oncology Next-Generation Sequencing market growth?
- What are the different segments of the Clinical Oncology Next-Generation Sequencing Market?
- What growth strategies are the players considering to increase their presence in Clinical Oncology Next-Generation Sequencing?
- What are the upcoming industry applications and trends for the Clinical Oncology Next-Generation Sequencing Market?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Clinical Oncology Next-Generation Sequencing Market?
- What major challenges could the Clinical Oncology Next-Generation Sequencing Market face in the future?
- What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
- Who are the leading companies and what are their portfolios in Clinical Oncology Next-Generation Sequencing Market?
- What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
- Who are the key players in the Clinical Oncology Next-Generation Sequencing market?
Click here for a more detailed explanation: https://www.maximizemarketresearch.com/request-sample/100383
Key Offerings:
- Past Market Size and Competitive Landscape (2021 to 2023)
- Past Pricing and price curve by region (2021 to 2023)
- Market Size, Share, Size & Forecast by different segment | 2024−2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by Region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Our Top-Rated Trending Articles:
Carpets and Rugs Market https://www.maximizemarketresearch.com/market-report/carpets-and-rugs-market/187345/
Flavor Enhancer Market https://www.maximizemarketresearch.com/market-report/global-flavor-enhancer-market/32455/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, IndiaC
+91 96071 95908, +91 9607365656
